Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Good prognosis for men with prostate cancer treated according to guidelines
Most men who are treated for prostate cancer according to modern guidelines have good survival…
ENDO 2025: Study finds strong link between acromegaly and increased cancer risk
People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing…
In sub-Saharan Africa, 1 in 6 cancer medications found to be defective
Serious quality defects were found in a significant number of cancer medications from sub-Saharan Africa,…
Patients are opting in for 10 years of breast cancer treatment
- ASKHER2 European survey shows perceived risk and fear of disease recurrence affect health behaviours and decision-making in women with early-stage HER2+ breast cancer
- Additional imaging techniques detect early stage cancers missed by mammograms in women with dense breasts
- ASCO 2025: Vepdegestrant could extend progression-free survival for some people with ESR1-mutated advanced breast cancer
Digital-first healthcare solutions to enhance patient experiences and outcomes
Greater uptake of digital-driven solutions in healthcare management could significantly improve patient experiences while saving providers time and money in…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.